Advertisement

FDA

— Medical

Expandable sponge-filled syringe that stems bleeding cleared for civilian use

A fast-acting medical device developed for emergency treatment of a gunshot or other penetrating wound on the battlefield has been cleared for civilian use by the US Food and Drug Administration (FDA). The XStat 30 is a plastic syringe that can stop severe bleeding within around 20 seconds through the injection of small sponges into a wound, and will now be available for use by the general population.

Read More
— Biology

Salmon the first genetically engineered animal to get FDA approval for human consumption

Following what it describes as an "exhaustive and rigorous scientific review," the US Food and Drug Administration (FDA) today announced the approval of the first ever genetically-modified animal for human consumption. The engineered salmon in question has had its DNA altered in such a way that it grows to market-ready size in around half the time of regular salmon, and has now been declared safe for humans and safe for the environment.

Read More
— Health & Wellbeing

FDA ticks off on drug to boost female libido

The first ever prescription pill to boost women's libido has won the approval of US regulators. Addyi got the final nod from the Food and Drug Administration (FDA) on Tuesday after three 24-week trials showed it to offer an increase in sexual desire in premenopausal women, though the agency does warn of side effects that include low blood pressure and fainting.

Read More
— 3D Printing

Approved by the FDA, 3D-printed drug set to change future of medication

The term "designer drug" may soon refer less to the illicit kind and more to custom creations by the pharmaceutical industry. Aprecia Pharmaceuticals Company has just had its proprietary ZipDose Technology platform approved by the US Food and Drug Administration (FDA). This marks the very first instance that the FDA has given the green light for a 3D-printed drug product.

Read More
— Medical

FDA approves blood test that predicts risk of coronary heart disease

Coronary heart disease (CHD) kills more than 385,000 people in the United States each year, and more than half of those who die suddenly have no previous symptoms. A new blood test that could reduce CHD-related illness and mortality by predicting the risk of future heart disease has been cleared by the US Food and Drug Administration (FDA). The PLAC Test for Lp-PLA2 screens for cardiovascular inflammation which can lead to a build up of rupture-prone plaque and result in a heart attack or stroke. Read More
— Health & Wellbeing

SensiumVitals could allow for near-constant observation of patients' vital signs

A new system developed by the Toumaz Group may hold the key to improving the level of life-saving attention received by patients, providing two-minute updates on their vital signs 24 hours a day with the use of a comfortable, wireless sensor pad. The equipment, known as SensiumVitals, is claimed to be so portable and convenient that it could even be used in the future to provide hospital-level observation to individuals in the comfort of their own homes. Read More
— Health & Wellbeing

FDA gives approval for DEKA prosthetic arm controlled by muscle impulses

Prosthetics have come a long way in recent years, with many artificial limbs incorporating advanced robotic and cybernetic systems that include everything up to and including mind control. Unfortunately, for all these advances, the lack of prosthetics capable of complex motor control means that most users see them as tools rather than replacement limbs. However, that may be changing as the US Food and Drug Administration (FDA) has announced approval for marketing of the DEKA Arm system, the first prosthetic arm set to hit the market that translates signals from a patient’s muscles to carry out complex tasks. Read More
— Science

Electric "thinking cap" helps people learn from their mistakes

Transcranial direct current stimulation (tDCS) has become a widely used technique for reaching into a person's brain and altering the way in which it functions. Vanderbilt psychology Professor Geoffrey Woodman and graduate student Robert Reinhart have just published the results of a new study in the Journal of Neuroscience in which they found that tDCS stimulation of the mediofrontal cortex for a period of minutes can change one's ability to recognize and learn from error for a period of several hours. Read More
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement